PIQ — Proteomics International Laboratories Income Statement
0.000.00%
Last trade - 00:00- AU$49.06m
- AU$38.09m
- AU$3.31m
Annual income statement for Proteomics International Laboratories, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.45 | 1.72 | 3.17 | 3.27 | 3.31 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4.3 | 6.7 | 9.55 | 10 | 11.6 |
| Operating Profit | -2.85 | -4.98 | -6.37 | -6.75 | -8.27 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2.86 | -4.97 | -6.23 | -6.48 | -8.15 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.86 | -4.97 | -6.23 | -6.48 | -8.15 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.86 | -4.97 | -6.18 | -6.38 | -8.11 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.86 | -4.97 | -6.18 | -6.38 | -8.11 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.03 | -0.047 | -0.053 | -0.051 | -0.06 |